KR20240135080A - 수지제 용기에 충전된 은염 함유 안과용 수성 조성물 - Google Patents

수지제 용기에 충전된 은염 함유 안과용 수성 조성물 Download PDF

Info

Publication number
KR20240135080A
KR20240135080A KR1020247029902A KR20247029902A KR20240135080A KR 20240135080 A KR20240135080 A KR 20240135080A KR 1020247029902 A KR1020247029902 A KR 1020247029902A KR 20247029902 A KR20247029902 A KR 20247029902A KR 20240135080 A KR20240135080 A KR 20240135080A
Authority
KR
South Korea
Prior art keywords
aqueous composition
ophthalmic aqueous
ophthalmic
silver
filled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247029902A
Other languages
English (en)
Korean (ko)
Inventor
유스케 모모카와
마키 이이다
히로유키 아사다
도요미 후지사와
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Publication of KR20240135080A publication Critical patent/KR20240135080A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
KR1020247029902A 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물 Pending KR20240135080A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020062252 2020-03-31
JPJP-P-2020-062252 2020-03-31
PCT/JP2021/007366 WO2021199814A1 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物
KR1020227037013A KR102705675B1 (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020227037013A Division KR102705675B1 (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Publications (1)

Publication Number Publication Date
KR20240135080A true KR20240135080A (ko) 2024-09-10

Family

ID=77930318

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020247029902A Pending KR20240135080A (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물
KR1020227037013A Active KR102705675B1 (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020227037013A Active KR102705675B1 (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Country Status (8)

Country Link
US (1) US20230145529A1 (https=)
EP (1) EP4129341A4 (https=)
JP (4) JP7053966B2 (https=)
KR (2) KR20240135080A (https=)
CN (1) CN115348871B (https=)
CA (1) CA3176584A1 (https=)
TW (1) TWI896607B (https=)
WO (1) WO2021199814A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022044701A (ja) * 2022-01-24 2022-03-17 参天製薬株式会社 インジェクションブロー成形されたマルチドーズ型点眼容器に収容される水性懸濁液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507469A (ja) 2013-02-15 2016-03-10 千寿製薬株式会社 抗菌性金属を含有するジフルプレドナートエマルション組成物
JP2017002036A (ja) 2015-06-05 2017-01-05 参天製薬株式会社 水性点眼液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP4683835B2 (ja) * 2003-12-01 2011-05-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
KR100557679B1 (ko) * 2004-01-07 2006-03-07 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
JP4856392B2 (ja) 2004-04-23 2012-01-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
US9629852B2 (en) * 2007-10-16 2017-04-25 Sun Pharma Advanced Research Company Ltd. Ophthalmic composition comprising a prostaglandin
JP5345743B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物キット
CN105073112B (zh) * 2013-03-13 2017-12-29 参天制药株式会社 睑板腺功能障碍的治疗剂
KR102330736B1 (ko) * 2014-12-25 2021-11-23 산텐 세이야꾸 가부시키가이샤 수성 점안액
JP6611444B2 (ja) * 2015-03-24 2019-11-27 ロート製薬株式会社 眼科用組成物
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
WO2019107569A1 (ja) * 2017-12-01 2019-06-06 参天製薬株式会社 眼科用製品
WO2020004247A1 (ja) * 2018-06-28 2020-01-02 株式会社Ｃｓｐアドバンスソリューションズ 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法
JP7139206B2 (ja) 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507469A (ja) 2013-02-15 2016-03-10 千寿製薬株式会社 抗菌性金属を含有するジフルプレドナートエマルション組成物
JP2017002036A (ja) 2015-06-05 2017-01-05 参天製薬株式会社 水性点眼液

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
비특허문헌 1 : 「무코스타(등록상표) 점안액 UD 2%」 첨부 문서
비특허문헌 2 : 「디쿠아스(등록상표) 점안액 3%」 첨부 문서
비특허문헌 3 : 질산은 점안액 「본해피(등록상표)」 첨부 문서

Also Published As

Publication number Publication date
JP2025146955A (ja) 2025-10-03
TWI896607B (zh) 2025-09-11
JP7169477B2 (ja) 2022-11-10
JP2022087168A (ja) 2022-06-09
CA3176584A1 (en) 2021-10-07
CN115348871B (zh) 2025-08-08
JP2023001184A (ja) 2023-01-04
EP4129341A4 (en) 2024-04-24
CN115348871A (zh) 2022-11-15
JP7721498B2 (ja) 2025-08-12
US20230145529A1 (en) 2023-05-11
TW202203920A (zh) 2022-02-01
JPWO2021199814A1 (https=) 2021-10-07
KR20220161379A (ko) 2022-12-06
JP7053966B2 (ja) 2022-04-12
EP4129341A1 (en) 2023-02-08
WO2021199814A1 (ja) 2021-10-07
KR102705675B1 (ko) 2024-09-11

Similar Documents

Publication Publication Date Title
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
JP2025146955A (ja) 樹脂製容器に充填された銀塩含有眼科用水性組成物
EP3706715B1 (en) Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof
JP2023093601A (ja) 眼科用製品
JP7144630B2 (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液
TW202604499A (zh) 填充於樹脂製容器之含銀鹽眼科用水性組合物
US11324829B2 (en) Antiseptic agent comprising meglumine or salt thereof
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物

Legal Events

Date Code Title Description
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240930

Comment text: Request for Examination of Application